Specificity profile of paroxetine in major depressive disorder: Meta-regression of double-blind, randomized clinical trials

Journal of Affective Disorders

Volumn 132, Issue 1-2, 2011, Pages 14-25

  Serretti, Alessandro ^a   Gibiino, Sara ^a   Drago, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antidepressant; Clinic profile; Depression; Paroxetine

Indexed keywords

AMFEBUTAMONE; AMISULPRIDE; AMITRIPTYLINE; CLOMIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SERTRALINE; TIANEPTINE; TRAZODONE; VENLAFAXINE;

CAUCASIAN; CONTROLLED DRUG RELEASE; DEMOGRAPHY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG SPECIFICITY; EMBASE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MEDLINE; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; SOCIAL ASPECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; PERSONALITY INVENTORY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SEX FACTORS; TREATMENT OUTCOME;

EID: 79958082772     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2010.08.018     Document Type: Review

References (105)

1. A. Aberg-Wistedt, H. Agren, L. Ekselius, F. Bengtsson, and A.C. Akerblad Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy J. Clin. Psychopharmacol. 20 2000 645 652
2. M. Ansseau, A. Gabriels, and J. Loyens Controlled comparison of paroxetine and fluvoxamine in major depression Hum. Psychopharmacol. 9 1994 329 336 (Pubitemid 24327606)
3. S.L. Arminen, U. Ikonen, P. Pulkkinen, E. Leinonen, A. Mahlanen, H. Koponen, K. Kourula, J. Ryyppo, V. Korpela, and M.L. Lehtonen A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients Acta Psychiatr. Scand. 89 1994 382 389 (Pubitemid 24210081)
4. D.S. Baldwin, C.J. Hawley, R.T. Abed, B.P. Maragakis, J. Cox, S.A. Buckingham, G.H. Pover, and A. Ascher A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression J. Clin. Psychiatry 57 Suppl 2 1996 46 52 (Pubitemid 26146709)
5. D.S. Baldwin, J.A. Cooper, A.K. Huusom, and I. Hindmarch A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder Int. Clin. Psychopharmacol. 21 2006 159 169 (Pubitemid 43740307)
6. L. Bascara A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients Acta Psychiatr. Scand. Suppl. 350 1989 141 142 (Pubitemid 19236663)
7. O. Benkert, A. Szegedi, and R. Kohnen Mirtazapine compared with paroxetine in major depression J. Clin. Psychiatry 61 2000 656 663
8. L. Bertilsson Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19 Clin. Pharmacokinet. 29 1995 192 209
9. L. Bertilsson, M.L. Dahl, and G. Tybring Pharmacogenetics of antidepressants: clinical aspects Acta Psychiatr. Scand. Suppl. 391 1997 14 21 (Pubitemid 27333214)
10. A. Bignamini, and V. Rapisarda A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group Int. Clin. Psychopharmacol. 6 Suppl 4 1992 37 41
11. M.B. Blom, P. Spinhoven, T. Hoffman, K. Jonker, E. Hoencamp, P.M. Haffmans, and R. van Dyck Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression J. Affect. Disord. 104 2007 119 126 (Pubitemid 350052321)
12. J.P. Boulenger, A.K. Huusom, I. Florea, T. Baekdal, and M. Sarchiapone A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients Curr. Med. Res. Opin. 22 2006 1331 1341 (Pubitemid 44085585)
13. G.B. Cassano, and M.C. Jori Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study Int. Clin. Psychopharmacol. 17 2002 27 32 (Pubitemid 34056522)
14. G. Chouinard, B. Saxena, M.C. Belanger, A. Ravindran, D. Bakish, L. Beauclair, P. Morris, N.P. Vasavan Nair, R. Manchanda, R. Reesal, R. Remick, and M.C. O'Neill A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder J. Affect. Disord. 54 1999 39 48 (Pubitemid 29287671)
15. P.E. Christiansen, K. Behnke, C.H. Black, J.K. Ohrstrom, H. Bork-Rasmussen, and J. Nilsson Paroxetine and amitriptyline in the treatment of depression in general practice Acta Psychiatr. Scand. 93 1996 158 163 (Pubitemid 26141605)
16. A. Cipriani, C. Barbui, P. Brambilla, T.A. Furukawa, M. Hotopf, and J.R. Geddes Are all antidepressants really the same? The case of fluoxetine: a systematic review J. Clin. Psychiatry 67 2006 850 864 (Pubitemid 44049083)
17. J. Claghorn A double-blind comparison of paroxetine and placebo in the treatment of depressed outpatients Int. Clin. Psychopharmacol. 6 Suppl 4 1992 25 30
18. J.L. Claghorn The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients J. Clin. Psychiatry 53 Suppl 1992 33 35
19. J.L. Claghorn, and J.P. Feighner A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression J. Clin. Psychopharmacol. 13 1993 23S 27S (Pubitemid 24025198)
20. J.L. Claghorn, A. Kiev, K. Rickels, W.T. Smith, and G.C. Dunbar Paroxetine versus placebo: a double-blind comparison in depressed patients J. Clin. Psychiatry 53 1992 434 438 (Pubitemid 23018086)
21. J.B. Cohn, and C.S. Wilcox Paroxetine in major depression: a double-blind trial with imipramine and placebo J. Clin. Psychiatry 53 Suppl 1992 52 56
22. J.B. Cohn, J.E. Crowder, C.S. Wilcox, and P.J. Ryan A placebo- and imipramine-controlled study of paroxetine Psychopharmacol. Bull. 26 1990 185 189 (Pubitemid 20291873)
23. J. De Wilde, R. Spiers, C. Mertens, F. Bartholome, G. Schotte, and S. Leyman A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients Acta Psychiatry Scand. 87 1993 141 145 (Pubitemid 23062205)
24. T. Dorman Sleep and paroxetine: a comparison with mianserin in elderly depressed patients Int. Clin. Psychopharmacol. 6 Suppl 4 1992 53 58
25. DUAG Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group J. Affect. Disord. 18 1990 289 299
26. G.C. Dunbar, J.B. Cohn, L.F. Fabre, J.P. Feighner, R.R. Fieve, J. Mendels, and R.K. Shrivastava A comparison of paroxetine, imipramine and placebo in depressed out-patients Br. J. Psychiatry 159 1991 394 398
27. G.C. Dunbar, J.L. Claghorn, A. Kiev, K. Rickels, and W.T. Smith A comparison of paroxetine and placebo in depressed outpatients Acta Psychiatr. Scand. 87 1993 302 305 (Pubitemid 23134636)
28. D.L. Dunner, J.B. Cohn, T. Walshe 3rd, C.K. Cohn, J.P. Feighner, R.R. Fieve, J.P. Halikas, J.T. Hartford, E.D. Hearst, and E.C. Settle Jr. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression J. Clin. Psychiatry 53 Suppl 1992 57 60
29. J.G. Edwards, and I. Anderson Systematic review and guide to selection of selective serotonin reuptake inhibitors Drugs 57 1999 507 533 (Pubitemid 29196919)
30. J.G. Edwards, and A. Goldie Placebo-controlled trial of paroxetine in depressive illness Hum. Psychopharmacol. 8 1993 203 209 (Pubitemid 23304060)
31. K. Esposito, and P. Goodnick Predictors of response in depression Psychiatr. Clin. North. Am. 26 2003 353 365 (Pubitemid 36583568)
32. L.F. Fabre A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients J. Clin. Psychiatry 53 Suppl 1992 40 43
33. M. Fava, J.D. Amsterdam, J.A. Deltito, C. Salzman, M. Schwaller, and D.L. Dunner A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression Ann. Clin. Psychiatry 10 1998 145 150 (Pubitemid 29078266)
34. M. Fava, J.F. Rosenbaum, S.L. Hoog, R.G. Tepner, J.B. Kopp, and M.E. Nilsson Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression J. Affect. Disord. 59 2000 119 126 (Pubitemid 30317428)
35. M. Fava, S.L. Hoog, R.A. Judge, J.B. Kopp, M.E. Nilsson, and J.S. Gonzales Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia J. Clin. Psychopharmacol. 22 2002 137 147 (Pubitemid 34289388)
36. J.P. Feighner A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients Int. Clin. Psychopharmacol. 6 Suppl 4 1992 31 35
37. J.P. Feighner, J.B. Cohn, L.F. Fabre Jr.; R.R. Fieve, J. Mendels, R.K. Shrivastava, and G.C. Dunbar A study comparing paroxetine placebo and imipramine in depressed patients J. Affect. Disord. 28 1993 71 79 (Pubitemid 23178094)
38. E. Freed, R. Goldney, T. Lambert, J. Tiller, and R. Johnston A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice Aust. N.Z. J. Psychiatry 33 1999 416 421 (Pubitemid 29312802)
39. C. Geretsegger, F. Bohmer, and M. Ludwig Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects Int. Clin. Psychopharmacol. 9 1994 25 29 (Pubitemid 24062648)
40. C. Geretsegger, C.H. Stuppaeck, M. Mair, T. Platz, R. Fartacek, and M. Heim Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients Psychopharmacology (Berl) 119 1995 277 281
41. W.S. Gilmer, J.K. Gollan, S.R. Wisniewski, R.H. Howland, M.H. Trivedi, S. Miyahara, J. Fleck, M.E. Thase, J.E. Alpert, A.A. Nierenberg, D. Warden, M. Fava, and A.J. Rush Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report J. Clin. Psychiatry 69 2008 1246 1256
42. R.N. Golden, C.B. Nemeroff, P. McSorley, C.D. Pitts, and E.M. Dube Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression J. Clin. Psychiatry 63 2002 577 584 (Pubitemid 34787322)
43. S. Greenland Quantitative methods in the review of epidemiologic literature Epidemiol. Rev. 9 1987 1 30
44. E. Guillibert, Y. Pelicier, J.C. Archambault, J.P. Chabannes, G. Clerc, M. Desvilles, M. Guibert, R. Pagot, J.L. Poisat, and Y. Thobie A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients Acta Psychiatr. Scand. Suppl. 350 1989 132 134 (Pubitemid 19236659)
45. W.E. Heydorn Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders Expert Opin. Investig. Drugs 8 1999 417 441 (Pubitemid 29164247)
46. J.A. Hicks, S.V. Argyropoulos, A.S. Rich, J.R. Nash, C.J. Bell, C. Edwards, D.J. Nutt, and S.J. Wilson Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression Br. J. Psychiatry 180 2002 528 535 (Pubitemid 34596804)
47. M.G. Hildebrandt, E.W. Steyerberg, K.B. Stage, J. Passchier, and P. Kragh-Soerensen Are gender differences important for the clinical effects of antidepressants? Am. J. Psychiatry 160 2003 1643 1650 (Pubitemid 41079551)
48. R.M. Hirschfeld, J.M. Russell, P.L. Delgado, J. Fawcett, R.A. Friedman, W.M. Harrison, L.M. Koran, I.W. Miller, M.E. Thase, R.H. Howland, M.A. Connolly, and R.J. Miceli Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine J. Clin. Psychiatry 59 1998 669 675 (Pubitemid 29068312)
49. R.H. Howland, M.G. Wilson, S.G. Kornstein, A.H. Clayton, M.H. Trivedi, M.M. Wohlreich, and M. Fava Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression Ann. Clin. Psychiatry 20 2008 209 218
50. D.R. Hutchinson, S. Tong, C.A. Moon, M. Vince, and A. Clarke Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline Int. Clin. Psychopharmacol. 6 Suppl 4 1992 43 51
51. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan, and H.J. McQuay Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin. Trials 17 1996 1 12 (Pubitemid 26120810)
52. M.W. Jann, and L.J. Cohen The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression Drug Metabol. Drug Interact. 16 2000 39 67 (Pubitemid 30090296)
53. S. Kasper, L. Olivieri, G. Di Loreto, and P. Dionisio A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder Curr. Med. Res. Opin. 21 2005 1139 1146 (Pubitemid 41140715)
54. C.L. Katona, B.N. Hunter, and J. Bray A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia Int. J. Geriatr. Psychiatry 13 1998 100 108 (Pubitemid 28077591)
55. M.A. Katzman, A.C. Tricco, D. McIntosh, M.J. Filteau, P. Bleau, P.R. Chokka, K.D. Kjernisted, H. Mok, and B. Pham Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis J. Clin. Psychiatry 68 2007 1845 1859
56. R.C. Kessler, P. Berglund, O. Demler, R. Jin, D. Koretz, K.R. Merikangas, A.J. Rush, E.E. Walters, and P.S. Wang The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) Jama 289 2003 3095 3105 (Pubitemid 37432885)
57. A. Kiev A double-blind, placebo-controlled study of paroxetine in depressed outpatients J. Clin. Psychiatry 53 Suppl 1992 27 29
58. A. Kiev, and A. Feiger A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients J. Clin. Psychiatry 58 1997 146 152 (Pubitemid 27199779)
59. S.G. Kornstein, A.F. Schatzberg, M.E. Thase, K.A. Yonkers, J.P. McCullough, G.I. Keitner, A.J. Gelenberg, S.M. Davis, W.M. Harrison, and M.B. Keller Gender differences in treatment response to sertraline versus imipramine in chronic depression Am. J. Psychiatry 157 2000 1445 1452
60. P.C. Lambert, A.J. Sutton, K.R. Abrams, and D.R. Jones A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis J. Clin. Epidemiol. 55 2002 86 94 (Pubitemid 34037039)
61. J. Lau, J.P. Ioannidis, and C.H. Schmid Summing up evidence: one answer is not always enough Lancet 351 1998 123 127 (Pubitemid 28026648)
62. A.L. Laursen, P.L. Mikkelsen, S. Rasmussen, and P. le Fevre Honore Paroxetine in the treatment of depression-a randomized comparison with amitriptyline Acta Psychiatry Scand. 71 1985 249 255 (Pubitemid 15169900)
63. P. Lee, L. Shu, X. Xu, C.Y. Wang, M.S. Lee, C.Y. Liu, J.P. Hong, S. Ruschel, J. Raskin, S.A. Colman, and G.A. Harrison Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil Psychiatry Clin. Neurosci. 61 2007 295 307 (Pubitemid 46684004)
64. J.P. Lepine, C. Altamura, M. Ansseau, J.L. Gutierrez, I. Bitter, M. Lader, and L. Waintraub Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study dagger Hum. Psychopharmacol. 16 2001 219 227 (Pubitemid 32421888)
65. G.M. McPartlin, A. Reynolds, and C. Anderson A comparison of once-daily venlafaxine XR and paroxetine in depressed outpatients treated in general practice Prim. Care Psychiatry 4 1998 127 132 (Pubitemid 28486588)
66. C. Mertens, and H. Pintens Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin Acta Psychiatry Scand. 77 1988 683 688
67. H.J. Moller, H. Berzewski, F. Eckmann, N. Gonzalves, W. Kissling, W. Knorr, P. Ressler, G.A. Rudolf, E.M. Steinmeyer, and I. Magyar Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients Pharmacopsychiatry 26 1993 75 78 (Pubitemid 23166387)
68. S.A. Montgomery, D.S. Baldwin, P. Blier, N.A. Fineberg, S. Kasper, M. Lader, R.W. Lam, J.P. Lepine, H.J. Moller, D.J. Nutt, F. Rouillon, A.F. Schatzberg, and M.E. Thase Which antidepressants have demonstrated superior efficacy? A review of the evidence Int. Clin. Psychopharmacol. 22 2007 323 329 (Pubitemid 47530836)
69. C.A. Moon, and M. Vince Treatment of major depression in general practice: a double-blind comparison of paroxetine and lofepramine Br. J. Clin. Pract. 50 1996 240 244
70. H. Morgenstern Uses of ecologic analysis in epidemiologic research Am. J. Public Health 72 1982 1336 1344
71. B.H. Mulsant, B.G. Pollock, R.D. Nebes, M.D. Miller, J.T. Little, J. Stack, P.R. Houck, S. Bensasi, S. Mazumdar, and C.F. Reynolds 3rd A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome J. Clin. Psychiatry 60 Suppl 20 1999 16 20 (Pubitemid 29468385)
72. B.H. Mulsant, B.G. Pollock, R. Nebes, M.D. Miller, R.A. Sweet, J. Stack, P.R. Houck, S. Bensasi, S. Mazumdar, and C.F. Reynolds 3rd A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients Am. J. Geriatr. Psychiatry 9 2001 406 414 (Pubitemid 33015128)
73. J.M. Murphy, R.R. Monson, D.C. Olivier, G.E. Zahner, A.M. Sobol, and A.H. Leighton Relations over time between psychiatric and somatic disorders: the Stirling County study Am. J. Epidemiol. 136 1992 95 105
74. C.J.L. Murray, and A.D. Lopez The global burden of disease and injury series, volume 1: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996 Harvard University Press Cambridge, MA
75. S. Ohrberg, P.E. Christiansen, B. Severin, H. Calberg, B. Nilakantan, A. Borup, J. Sogaard, S.B. Larsen, D. Loldrup, and B. Bahr Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice Acta Psychiatry Scand. 86 1992 437 444
76. D.G. Perahia, D.K. Kajdasz, M.G. Royer, D.J. Walker, and J. Raskin Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics Int. Clin. Psychopharmacol. 21 2006 285 295 (Pubitemid 44162481)
77. S. Pini, X.F. Amador, L. Dell'Osso, N. Baldini Rossi, P. Cassano, M. Savino, and G.B. Cassano Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide Int. Clin. Psychopharmacol. 18 2003 15 21 (Pubitemid 36127056)
78. A. Pinto-Meza, J. Usall, A. Serrano-Blanco, D. Suarez, and J.M. Haro Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference? J. Affect. Disord. 93 2006 53 60 (Pubitemid 43833246)
79. M.F. Poirier, and P. Boyer Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison Br. J. Psychiatry 175 1999 12 16 (Pubitemid 29307849)
80. F.M. Quitkin, J.W. Stewart, P.J. McGrath, B.P. Taylor, M.S. Tisminetzky, E. Petkova, Y. Chen, G. Ma, and D.F. Klein Are there differences between women's and men's antidepressant responses? Am. J. Psychiatry 159 2002 1848 1854 (Pubitemid 35283249)
81. M.H. Rapaport, L.S. Schneider, D.L. Dunner, J.T. Davies, and C.D. Pitts Efficacy of controlled-release paroxetine in the treatment of late-life depression J. Clin. Psychiatry 64 2003 1065 1074 (Pubitemid 37158252)
82. A.V. Ravindran, R. Judge, B.N. Hunter, J. Bray, and N.H. Morton A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group J. Clin. Psychiatry 58 1997 112 118 (Pubitemid 27149252)
83. A.J. Rush, S.R. Wisniewski, D. Warden, J.F. Luther, L.L. Davis, M. Fava, A.A. Nierenberg, and M.H. Trivedi Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features Arch. Gen. Psychiatry 65 2008 870 880
84. A. Sacchetti, G.B. Cassano, and G. Penati Paroxetine versus amitriptyline in patients with recurrent major depression: a double-blind trial Int. J. Psychiatry Clin. Pract. 6 2000 23 29
85. A.F. Schatzberg, C. Kremer, H.E. Rodrigues, and G.M. Murphy Jr. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients Am. J. Geriatr. Psychiatry 10 2002 541 550 (Pubitemid 34984390)
86. U. Schnyder, and A. Koller-Leiser A double-blind, multicentre study of paroxetine and maprotiline in major depression Can. J. Psychiatry 41 1996 239 244 (Pubitemid 26191195)
87. W. Schone, and M. Ludwig A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression J. Clin. Psychopharmacol. 13 1993 34S 39S (Pubitemid 24025200)
88. A. Serretti, C. Cusin, J.L. Rausch, B. Bondy, and E. Smeraldi Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis Psychiatry Res. 145 2006 61 65 (Pubitemid 44709196)
89. A. Serretti, M. Kato, D. De Ronchi, and T. Kinoshita Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients Mol. Psychiatry 12 2007 247 257 (Pubitemid 46328503)
90. A. Serretti, R. Zanardi, L. Mandelli, E. Smeraldi, and C. Colombo A neural network model for combining clinical predictors of antidepressant response in mood disorders J. Affect. Disord. 98 2007 239 245 (Pubitemid 46149064)
91. A. Serretti, A. Chiesa, R. Calati, G. Perna, L. Bellodi, and D. De Ronchi Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders Int. Clin. Psychopharmacol. 24 2009 1 18
92. R.K. Shrivastava, S.H. Shrivastava, N. Overweg, and C.L. Blumhardt A double-blind comparison of paroxetine, imipramine, and placebo in major depression J. Clin. Psychiatry 53 Suppl 1992 48 51
93. W.T. Smith, and V. Glaudin A placebo-controlled trial of paroxetine in the treatment of major depression J. Clin. Psychiatry 53 1992 36 39
94. L.A. Stewart, and M.J. Clarke Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group Stat. Med. 14 1995 2057 2079
95. C.H. Stuppaeck, C. Geretsegger, A.B. Whitworth, H. Schubert, T. Platz, P. Konig, H. Hinterhuber, and W.W. Fleischhacker A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients J. Clin. Psychopharmacol. 14 1994 241 246 (Pubitemid 24254715)
96. A. Szegedi, H. Wetzel, D. Angersbach, M. Philipp, and O. Benkert Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline J. Affect. Disord. 45 1997 167 178 (Pubitemid 27373695)
97. S.W. Tang, and D. Helmeste Paroxetine Expert Opin. Pharmacother. 9 2008 787 794 (Pubitemid 351566194)
98. J. Tignol A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression J. Clin. Psychopharmacol. 13 1993 18S 22S (Pubitemid 24025197)
99. M.H. Trivedi, A.J. Rush, S.R. Wisniewski, A.A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R.H. Howland, B. Lebowitz, P.J. McGrath, K. Shores-Wilson, M.M. Biggs, G.K. Balasubramani, and M. Fava Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am. J. Psychiatry 163 2006 28 40 (Pubitemid 43050100)
100. H.L. Van, J. Dekker, J. Peen, G. van Aalst, and R.A. Schoevers Identifying patients at risk of complete nonresponse in the outpatient treatment of depression Psychother. Psychosom. 77 2008 358 364
101. A. Wade, G.M. Crawford, M. Angus, R. Wilson, and L. Hamilton A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care Int. Clin. Psychopharmacol. 18 2003 133 141 (Pubitemid 36571056)
102. A.J. Wagstaff, S.M. Cheer, A.J. Matheson, D. Ormrod, and K.L. Goa Paroxetine: an update of its use in psychiatric disorders in adults Drugs 62 2002 655 703 (Pubitemid 34264033)
103. L. Waintraub, L. Septien, and P. Azoulay Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine CNS Drugs 16 2002 65 75 (Pubitemid 34151338)
104. K.L. Weihs, E.C. Settle Jr.; S.R. Batey, T.L. Houser, R.M. Donahue, and J.A. Ascher Bupropion sustained release versus paroxetine for the treatment of depression in the elderly J. Clin. Psychiatry 61 2000 196 202 (Pubitemid 30214516)
105. G. Winterer, M. Ziller, and M. Linden Classification of observational data with artificial neural networks versus discriminant analysis in pharmacoepidemiological studies-can outcome of fluoxetine treatment be predicted? Pharmacopsychiatry 31 1998 225 231 (Pubitemid 29022040)